The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

X.d

Lupus - Lupus syndrome (see also Vd)

Publications

Jonas BL, Lim M, Agudelo CA

Chlorpromazine-induced lupus with cardiac tamponade.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 1995;1(1):60-2

Sarzi-Puttini P, Atzeni F, Capsoni F, Lubrano E, Doria A

Drug-induced lupus erythematosus.

Autoimmunity. 2005;38(7):507-18

Price EJ, Venables PJ

Drug-induced lupus.

Drug safety. 1995;12(4):283-90

Roche-Bayard P, Rossi R, Mann JM, Cordier JF, Delahaye JP

Left pulmonary artery thrombosis in chlorpromazine-induced lupus.

Chest. 1990;98(6):1545